Development of systemic lupus erythematosus in a male-to-female transsexual: The role of sex hormones revisited

Lupus

Volumn 22, Issue 13, 2013, Pages 1399-1402

  Chan, K L ^a   Mok, C C ^a  

^a TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

androgen; estrogen; gender; lupus; male; Sex hormone; transsexual

Indexed keywords

ANTINUCLEAR ANTIBODY; CONJUGATED ESTROGEN; GLUCOSE; IMMUNOSUPPRESSIVE AGENT; NEUROLEPTIC AGENT; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SM ANTIBODY; WARFARIN;

ACUTE PSYCHOSIS; ADULT; ARTICLE; AUDITORY HALLUCINATION; CASE REPORT; DEEP VEIN THROMBOSIS; DISEASE COURSE; DISORIENTATION; DOPPLER FLOWMETRY; DRUG MEGADOSE; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; ESTROGEN THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERNATIONAL NORMALIZED RATIO; LYMPHOCYTE COUNT; MALE TO FEMALE TRANSSEXUAL; MEDICAL HISTORY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PSYCHIATRIST; SEX REASSIGNMENT; SWELLING; SYSTEMIC LUPUS ERYTHEMATOSUS; VERBAL COMMUNICATION;

ANDROGEN; ESTROGEN; GENDER; LUPUS; MALE; SEX HORMONE; TRANSSEXUAL;

ADULT; ANTIPSYCHOTIC AGENTS; AUTOANTIBODIES; AUTOIMMUNITY; BIOLOGICAL MARKERS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; RISK FACTORS; SEX REASSIGNMENT SURGERY; TESTOSTERONE; TRANSGENDERED PERSONS; TRANSSEXUALISM;

EID: 84887096133     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313500550     Document Type: Article

References (20)

1. French MA, Hughes P. Systemic lupus erythematosus and Klinefelter's syndrome. Ann Rheum Dis. 1983 ; 42: 471-473
2. Roubinian JR, Talal N, Greenspan JS, Goodman JR, Siiteri PK. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med. 1978 ; 147: 1568-1583
3. Lucas JA, Ahmed SA, Casey ML, MacDonald PC. Prevention of autoantibody formation and prolonged survival in New Zealand black/New Zealand white F1 mice fed dehydroisoandrosterone. J Clin Invest. 1985 ; 75: 2091-2093
4. Verheul HA, Verveld M, Hoefakker S, Schuurs AH. Effects of ethinylestradiol on the course of spontaneous autoimmune disease in NZB/W and NOD mice. Immunopharmacol Immunotoxicol. 1995 ; 17: 163-180
5. Roubinian JR, Papoian R, Talal N. Androgenic hormones modulate autoantibody responses and improve survival in murine lupus. J Clin Invest. 1977 ; 59: 1066-1070
6. Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012 ; 64: 2677-2686
7. Grimaldi CM, Cleary J, Dagtas AS, Moussai D, Diamond B. Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest. 2002 ; 109: 1625-1633
8. Kim WU, Min SY, Hwang SH, Yoo SA, Kim KJ, Cho CS. Effect of oestrogen on T cell apoptosis in patients with systemic lupus erythematosus. Clin Exp Immunol. 2010 ; 161: 453-458
9. Rider V, Jones S, Evans M, Bassiri H, Afsar Z, Abdou NI. Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus. J Rheumatol. 2001 ; 28: 2644-2649
10. Sánchez-Guerrero J, Karlson EW, Liang MH, Hunter DJ, Speizer FE, Colditz GA. Past use of oral contraceptives and the risk of developing systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 804-808
11. Sánchez-Guerrero J, Liang MH, Karlson EW, Hunter DJ, Colditz GA. Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus. Ann Intern Med. 1995 ; 122: 430-433
12. Petri M, Kim MY, Kalunian KC, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005 ; 353: 2550-2558
13. Buyon JP, Petri MA, Kim MY, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: A randomized trial. Ann Intern Med. 2005 ; 142: 953-962
14. Sawalha AH, Kovats S. Dehydroepiandrosterone in systemic lupus erythematosus. Curr Rheumatol Rep. 2008 ; 10: 286-291
15. Inserra P, Zhang Z, Ardestani SK, et al. Modulation of cytokine production by dehydroepiandrosterone plus melatonin supplementation of old mice. Proc Soc Exp Biol Med. 1998 ; 218: 76-82
16. Kanda N, Tsuchida T, Tamaki K. Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1703-1711
17. Chang DM, Chu SJ, Chen HC, Kuo SY, Lai JH. Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus. Ann Rheum Dis. 2004 ; 63: 1623-1626
18. Suzuki T, Suzuki N, Engleman EG, Mizushima Y, Sakane T. Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol. 1995 ; 99: 251-255
19. Crosbie D, Black C, McIntyre L, Royle PL, Thomas S. Dehydroepiandrosterone for systemic lupus erythematosus. Cochrane Database Syst Rev. 2007 ; 4: CD005114 - CD005114
20. Zandman-Goddard G, Solomon M, Barzilai A, Shoenfeld Y. Lupus erythematosus tumidus induced by sex reassignment surgery. J Rheumatol. 2007 ; 34: 1938-1940